abstract |
The present invention provides a molecule that specifically binds to thymic stromal lymphogenic factor (TSLP). A molecule that specifically binds to an epitope in human TSLP, wherein the epitope comprises the following residues: Lys38, Ala41, Leu44, Ser45, Thr46, Ser48, Lys49, Ile52 of a specific amino acid sequence. , A molecule comprising at least one of Thr53, Ser56, Gly57, Thr58, Lys59, Lys101, Gln145, and Arg149. [Selection figure] None |